Lineage Cell Therapeutics In shares owned by Laurion Capital Management
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Laurion Capital Management
from 13F filings
Historical chart of Laurion Capital Management investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Laurion Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Laurion Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $56k | 62k | 0.91 |
| 2023-12-31 | $473k | 434k | 1.09 |
| 2023-09-30 | $1.3M | 1.1M | 1.18 |
| 2023-06-30 | $2.8M | 2.0M | 1.41 |
| 2023-03-31 | $3.6M | 2.4M | 1.50 |
| 2022-12-31 | $2.8M | 2.4M | 1.17 |
| 2022-09-30 | $2.7M | 2.4M | 1.13 |
| 2022-06-30 | $3.8M | 2.4M | 1.58 |
| 2020-06-30 | $11k | 13k | 0.88 |
More positions owned by Laurion Capital Management
View all positions for Laurion Capital Management